Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.

The management of Crohn's disease is rapidly changing. The advent of potent immunomodulatory and biologic therapies has led to more demanding endpoints for clinical trials than only clinical response and remission. Complete withdrawal of corticosteroids, healing of endoscopically visible lesion...

Full description

Bibliographic Details
Main Authors:	D'Haens, G, Fedorak, R, Lémann, M, Feagan, BG, Kamm, M, Cosnes, J, Rutgeerts, P, Marteau, P, Travis, S, Schölmerich, J, Hanauer, S, Sandborn, W
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.
by: Gottlieb, K, et al.
Published: (2015)

Development of the Crohn's disease digestive damage score, the Lemann score.
by: Pariente, B, et al.
Published: (2011)

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.
by: Peyrin-Biroulet, L, et al.
Published: (2012)

Evolving concepts in phases I and II drug development for Crohn's Disease
by: Jairath, V, et al.
Published: (2016)

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.
by: Gasche, C, et al.
Published: (2000)

Evolving concepts in Phase I and II Drug Development for Crohn's Disease.
by: Jairath, V, et al.
Published: (2016)

The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice
by: Sandborn, W, et al.
Published: (2016)

American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
by: Clark, M, et al.
Published: (2007)

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.
by: Travis, S, et al.
Published: (2006)

The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy.
by: Travis, S, et al.
Published: (2012)

Biomarker correlation with endoscopic outcomes in patients with Crohn's disease: data from CALM
by: Reinisch, W, et al.
Published: (2018)

Crohn’s disease or Crohn’s diseases?
by: Arnott, IDR, et al.
Published: (2003)

Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: an IOIBD initiative
by: Danese, S, et al.
Published: (2015)

Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn's disease
by: Jairath, V, et al.
Published: (2016)

Standardizing scoring conventions for Crohn’s disease endoscopy: An international RAND/UCLA appropriateness study
by: Khanna, R, et al.
Published: (2023)

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
by: Colombel, J, et al.
Published: (2017)

Medical management of Crohn's disease.
by: Cummings, JR, et al.
Published: (2008)

Is Crohn's disease a rightly used eponym?
by: Van Hootegem, P, et al.
Published: (2019)

Interfering with leukocyte trafficking in Crohn's disease
by: Biswas, S, et al.
Published: (2019)

Mortality in patients hospitalised with Crohn's disease.
by: Siffledeen, J, et al.
Published: (2012)

Smoking status in therapeutic trials in Crohn's disease.
by: McGovern, D, et al.
Published: (2005)

Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
by: Panaccione, R, et al.
Published: (2019)

The genetic prediction of the clinical response to infliximab in Crohn's disease (CD): A role for polymorphisms in the TNFa and LTA genes?
by: De Silva, A, et al.
Published: (2002)

Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis
by: Samaan, MA, et al.
Published: (2018)

Crohn's disease and pregnancy.
by: Khosla, R, et al.
Published: (1984)

Perianal Crohn's disease.
by: Singh, B, et al.
Published: (2004)

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
by: Van Assche, G, et al.
Published: (2010)

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.
by: Stange, E, et al.
Published: (2006)

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
by: D'Haens, G, et al.
Published: (2011)

Stress-related consequences of the coronavirus disease 2019 pandemic on symptoms of Crohn's disease
by: Goodday, SM, et al.
Published: (2021)

Central Endoscopy Reading in Inflammatory Bowel Diseases
by: Panés, J, et al.
Published: (2016)

Review article: insurance risks for patients with ulcerative colitis or Crohn's disease.
by: Travis, S
Published: (1997)

Systematic review and meta-analysis: Prevalence, risk factors, and costs of aminosalicylate use in Crohn’s disease
by: Ma, C, et al.
Published: (2018)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
by: Travis, S, et al.
Published: (2012)

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.
by: Dignass, A, et al.
Published: (2010)

Immunosuppression for management of Crohn's disease
by: Milosevic, I, et al.
Published: (2016)

Field Cancerization in Crohn's Disease
by: Graham, T, et al.
Published: (2010)

NOD2 SIGNALLING IN CROHN'S DISEASE
by: Allan, P, et al.
Published: (2011)

AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study.
by: Reinisch, W, et al.
Published: (2014)

Biosimilars in IBD: hope or expectation?
by: Gecse, K, et al.
Published: (2013)